Savant Capital LLC cut its stake in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 3.0% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 44,309 shares of the company’s stock after selling 1,348 shares during the period. Savant Capital LLC’s holdings in Cardinal Health were worth $4,466,000 at the end of the most recent reporting period.
Other large investors have also recently added to or reduced their stakes in the company. Cornerstone Planning Group LLC bought a new stake in Cardinal Health in the third quarter worth approximately $26,000. BKM Wealth Management LLC acquired a new position in shares of Cardinal Health during the 4th quarter valued at about $30,000. Wetzel Investment Advisors Inc. bought a new position in shares of Cardinal Health in the 4th quarter valued at approximately $36,000. Headlands Technologies LLC acquired a new stake in Cardinal Health in the 3rd quarter worth approximately $47,000. Finally, McGlone Suttner Wealth Management Inc. acquired a new position in Cardinal Health during the fourth quarter valued at approximately $59,000. Institutional investors and hedge funds own 87.17% of the company’s stock.
Cardinal Health Stock Performance
Shares of Cardinal Health stock opened at $102.17 on Thursday. The firm has a market cap of $24.85 billion, a P/E ratio of 40.22, a price-to-earnings-growth ratio of 1.04 and a beta of 0.71. The firm’s 50-day simple moving average is $109.43 and its 200-day simple moving average is $105.00. Cardinal Health, Inc. has a twelve month low of $77.56 and a twelve month high of $116.04.
Cardinal Health Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were paid a $0.5006 dividend. This represents a $2.00 annualized dividend and a yield of 1.96%. The ex-dividend date was Thursday, March 28th. Cardinal Health’s dividend payout ratio is 78.74%.
Analysts Set New Price Targets
Several research firms recently issued reports on CAH. Barclays started coverage on shares of Cardinal Health in a report on Wednesday, January 3rd. They set an “overweight” rating and a $117.00 price objective for the company. StockNews.com upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Thursday. SVB Leerink initiated coverage on Cardinal Health in a research note on Monday, February 26th. They set an “outperform” rating and a $125.00 target price for the company. UBS Group lifted their price target on Cardinal Health from $122.00 to $125.00 and gave the stock a “buy” rating in a research report on Monday, February 5th. Finally, Argus raised Cardinal Health from a “hold” rating to a “buy” rating in a research report on Friday, February 9th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $102.93.
Check Out Our Latest Research Report on CAH
About Cardinal Health
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Stories
- Five stocks we like better than Cardinal Health
- Trading Stocks: RSI and Why it’s Useful
- How to Use Put Credit Spreads to Catch Falling Knives More Safely
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Starbucks: Indicators Turns Bearish, New Lows in Sight
- Investing in the High PE Growth Stocks
- Kraft Heinz: Serving Up A Tasty Dip for Investors to Snack On
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.